최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.44 no.3, 2023년, pp.366 - 386
박지원 (경희대학교 대학원 임상한의학과 폐계내과학교실) , 이범준 (경희대학교 대학원 임상한의학과 폐계내과학교실) , 신정원 (경희대학교 대학원 임상한의학과 폐계내과학교실) , 진수현 (경희대학교 대학원 임상한의학과 폐계내과학교실) , 양정민 (경희대학교 대학원 임상한의학과 폐계내과학교실) , 김수덕 (경희대학교 대학원 임상한의학과 폐계내과학교실) , 김관일 (경희대학교 대학원 임상한의학과 폐계내과학교실) , 최혜숙 (경희의료원 내과) , 정희재 (경희대학교 대학원 임상한의학과 폐계내과학교실)
Objective: In this study, a questionnaire survey was conducted for doctors and patients to obtain basic data necessary for the development of an integrated medical system for idiopathic pulmonary fibrosis (IPF). Methods: Questionnaires were developed separately for doctors and patients through an ex...
King Jr TE, Pardo A, Selman M. Idiopathic?pulmonary fibrosis. The Lancet 2011;378(9807):1949-61.
Richeldi L, Collard HR, Jones MG. Idiopathic?pulmonary fibrosis. The Lancet 2017;389(10082):1941-52.
Raghu G, Amatto VC, Behr J, Stowasser S.?Comorbidities in idiopathic pulmonary fibrosis?patients: a systematic literature review. European?Respiratory Journal 2015;46(4):1113-30.
Khor YH, Ng Y, Barnes H, Goh NSL, McDonald?CF, Holland AE. Prognosis of idiopathic pulmonary?fibrosis without anti-fibrotic therapy: a systematic?review. European Respiratory Review 2020;29(157):190158.
Kim SW, Myong JP, Yoon HK, Koo JW, Kwon?SS, Kim YH. Health care burden and medical?resource utilisation of idiopathic pulmonary fibrosis?in Korea. Int J Tuberc Lung Dis 2017;21(2):230-5.
Zaman T, Lee JS. Risk factors for the development?of idiopathic pulmonary fibrosis: A review. Curr?Pulmonol Rep 2018;7(4):118-25.
Cox IA, Borchers Arriagada N, de Graaff B, Corte?TJ, Glaspole I, Lartey S, et al. Health-related?quality of life of patients with idiopathic pulmonary?fibrosis: a systematic review and meta-analysis.?European Respiratory Review 2020;29(158):200154.
Gao J, Kalafatis D, Carlson L, Pesonen IH, Li?CX, Wheelock A, et al. Baseline characteristics?and survival of patients of idiopathic pulmonary?fibrosis: a longitudinal analysis of the Swedish?IPF Registry. Respiratory research 2021;22(1):40.
Noble PW, Albera C, Bradford WZ, Costabel U,?Du Bois RM, Fagan EA, et al. Pirfenidone for?idiopathic pulmonary fibrosis: analysis of pooled?data from three multinational phase 3 trials.?European Respiratory Journal 2016;47(1):243-53.
Lancaster L, Crestani B, Hernandez P, Inoue?Y, Wachtlin D, Loaiza L, et al. Safety and?survival data in patients with idiopathic?pulmonary fibrosis treated with nintedanib:?pooled data from six clinical trials. BMJ Open?Respiratory Research 2019;6(1):e000397.
Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche?J, Prasse A, et al. Health related quality of?life in patients with idiopathic pulmonary fibrosis?in clinical practice: insights-IPF registry. Respiratory?research 2017;18(1):139.
Kim ES, Keating GM. Pirfenidone: a review of?its use in idiopathic pulmonary fibrosis. Drugs?2015;75(2):219-30.
Margaritopoulos GA, Trachalaki A, Wells AU,?Vasarmidi E, Bibaki E, Papastratigakis G, et al.?Pirfenidone improves survival in IPF: results?from a real-life study. BMC pulmonary medicine?2018;18(1):177.
Cohen MH. Complementary and integrative medical?therapies, the FDA, and the NIH: definitions?and regulation. Dermatologic therapy 2003;16(2):77-84.
Ji K, Ma J, Wang L, Li N, Dong S, Shi L.?Efficacy and safety of traditional Chinese?medicine in idiopathic pulmonary fibrosis: a?meta-analysis. Evidence-Based Complementary?and Alternative Medicine 2020;2020:1752387.
Kalnins P, Brucker M, Spears D. Prolonged?Survival in a Patient with Idiopathic Pulmonary?Fibrosis Receiving Acupuncture and DHEA-Promoting Herbs with Conventional Management:?A Case Report. The Permanente Journal 2019;23:18-074.
Li B, Zhang Y, Yang QM. Umbilical moxibustion?for patients with idiopathic pulmonary fibrosis?complicated with gastroesophageal reflux of?lung-spleen qi deficiency. Chinese Acupuncture?& Moxibustion 2019;39(3):241-5.
Yu X, Li X, Wang L, Liu R, Xie Y, Li S, et al.?Pulmonary rehabilitation for exercise tolerance?and quality of life in IPF patients: a systematic?review and meta-analysis. BioMed research?international 2019;2019:8498603.
Guler SA, Lindell KO, Swigris J, Ryerson CJ.?Nondrug Treatments for Idiopathic Pulmonary?Fibrosis: IPF Part 3. American journal of?respiratory and critical care medicine 2021;203(4):P10-P11.
Mercader-Barcelo J, Truyols-Vives J, Rio C,?Lopez-Safont N, Sala-Llinas E, Chaplin A.?Insights into the role of bioactive food ingredients?and the microbiome in idiopathic pulmonary?fibrosis. International Journal of Molecular Sciences?2020;21(17):6051.
Duck A, Pigram L, Errhalt P, Ahmed D, Chaudhuri?N. IPF Care: a support program for patients?with idiopathic pulmonary fibrosis treated with?pirfenidone in Europe. Advances in therapy?2015;32(2):87-107.
Lee HY, Lee DH, Lee GE, Kim JH, Kim HM,?Kim NK. Survey on the satisfaction and demand?of healthcare providers who participated in a?collaborative first-stage pilot project between?Korean medicine and western medicine. Journal?of physiology & pathology in Korean Medicine?2018;32(2):134-40.
Li M, Wu R, Zhao Y, Li L, Li G, Liu S, et al.?Chinese Herbal Medicine for Idiopathic Pulmonary?Fibrosis: An Overview of Systematic Review.?Alternative Therapies in Health and Medicine?2023:AT8195.
Kim Y, Lee Y, Yoon S, Huh J. Nutritional?factors affecting the mortality in patients with?chronic lung disease. Current Developments in?Nutrition 2020;4(Supplement_2):41.
Volpato E, Banfi P, Rogers SM, Pagnini F.?Relaxation techniques for people with chronic?obstructive pulmonary disease: a systematic?review and a meta-analysis. Evidence-Based?Complementary and Alternative Medicine 2015;2015:628365.
Choi WI. Current and future treatment for?idiopathic pulmonary fibrosis. Journal of the?Korean Medical Association 2021;64(4):256-63.
Shimizu Y, Shimoyama Y, Kawada A, Kusano M,?Hosomi Y, Sekiguchi M, et al. Gastrointestinal?symptoms in idiopathic pulmonary fibrosis?patients treated with pirfenidone and herbal?medicine. Journal of Biological Regulators and?Homeostatic Agents 2014;28(3):433-42.
Park JE, Kwon SM. Determinants of the utilization?of oriental medical services by the elderly. The?Journal of Korean Medicine 2011;32(1):97-108.
Vainshelboim B, Oliveira J, Izhakian S, Unterman?A, Kramer MR. Lifestyle Behaviors and Clinical?Outcomes in Idiopathic Pulmonary Fibrosis.?Respiration 2018;95(1):27-34.
Poswal FS, Russell G, Mackonochie M, MacLennan?E, Adukwu EC, Rolfe V. Herbal teas and their?health benefits: a scoping review. Plant Foods?for Human Nutrition 2019;74(3):266-76.
Van Manen M, Kreuter M, Van Den Blink B,?Oltmanns U, Baroke E, Palmowski K, et al.?What patients with pulmonary fibrosis and?their partners really think; live patient and?partner survey on pulmonary fibrosis in the?netherlands and germany. A41. Here there and?everywhere: ILD observational studies: American?Thoracic Society 2015;191:A1591.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.